Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Ultrasound Equipment...

    Ultrasound Equipment now classified as DRUGS, under purview DCA: Gazette notification

    Farhat NasimWritten by Farhat Nasim Published On 2019-10-20T11:41:15+05:30  |  Updated On 20 Oct 2019 11:41 AM IST
    Ultrasound Equipment now classified as DRUGS, under purview DCA: Gazette notification

    New Delhi: Through a recent notification, apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has notified Ultrasound Device as "Drugs" effective from November 2020. With this, import, manufacture and sale of the ultrasound machines will be allowed only under the legal ambit of the Drugs and Cosmetics Act, 1940.


    Medical ultrasound (also known as diagnostic sonography or ultrasonography) is a diagnostic imaging technique based on the application of ultrasound that generally aims to find a source of a disease or to exclude pathology using an ultrasound machine. However, the machine is often misused, violating the provisions of The Pre-Conception and Pre Natal Diagnostic Techniques (PC-PNDT) Act by conducting illegal sex determination tests after conception.


    The classification of the ultrasound machine as DRUGS will expand the horizon of regulating the equipment. In 2018, the Drug Technical Advisory Board (DTAB) had decided to include ultrasound equipment under the purview of the Drugs and Cosmetics Act, 1940 in order to save the girl child as the stern rule of ultrasound machines is thought to be critical in addressing the drastic imbalance in India’s sex ratio.


    Also Read: Ultrasound, CT scanners, MRI, X-Ray to fall under Drugs Act: Drug Technical Advisory Board


    The Ministry of Health and Family Welfare has recently come up with a released dated October 16, 2019, that stated;




    In pursuance of sub-clause (iv) of clause (b) of section 3 of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government, after consultation with the Drugs Technical Advisory Board, hereby specifies the following device intended for external or internal use in human beings as drug with effect from the 1st day of November, 2020, namely:― “Ultrasound equipment”.



    Prior to this, the ministry had notified all implantable medical devices, CT scan, MRI equipment, defibrillators, dialysis machine, PET equipment, X-ray machine and bone marrow cell separator will be regulated as “drugs” to provide safety to patients and regulate the quality of diagnostic and medical devices in India.


    Also Read: Eight medical devices including CT, MRI, X-ray notified as DRUGS by the Health ministry

    CDSCOCentral Drugs Standard Control OrganizationDrug Technical Advisory BoarddrugsDrugs and Cosmetics ActDTABMedical DevicesPNDTsonographyUltrasoundultrasound equipmentultrasound machinexray

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok